University OF Texas/texas AM Investment Management Co., 10% Owner at Aileron Therapeutics, Inc. (ALRN), sold 10,836 shares at $4.92 ($54K) on 2024-04-29, disclosed to the SEC on 2024-05-01.
Open-market sale of $54k ALRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.92 | 6,680 | $33K | 61.3% |
| 2 | $4.93 | 274 | $1K | 2.5% |
| 3 | $4.94 | 100 | $494 | 0.9% |
| 4 | $5.00 | 3,231 | $16K | 30.1% |
| 5 | $5.01 | 13 | $65 | 0.1% |
| 6 | $5.03 | 448 |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateSilver Point Specialty Lending Fund | BUY | 2026-03-02 | $6.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY |
| $2K |
| 4.2% |
| 7 | $4.95 | 45 | $223 | 0.4% |
| 8 | $5.00 | 45 | $225 | 0.4% |
| Total | $4.95 avg | 10,836 | $54K | 100% |
| 2026-02-02 |
| $9.7M |
| — |
| Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-12-29 | $8.6M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-11-26 | $8.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-10-27 | $7.6M | — | Filing → |